Endo-BCN-PEG4-Pomalidomide is a PEG derivative comprised of BCN, PEG4, and Pomalidomide. The BCN group exhibits high reactivity with azide-labeled molecules. Its amino group reacts with carboxylic acids, activated NHS esters, and carbonyl compounds (ketones, aldehydes), among others.
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted